OR WAIT null SECS
© 2023 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Applied Clinical Trials
SAN DIEGO (June 15, 2015) --- Parallel 6, an innovator in enterprise mobile engagement and management solutions, and Sentrian™, the Remote Patient Intelligence™ company aspiring to eliminate all preventable hospitalization, announced today as technology partners, Clinical Reach’s Reachlink Connector will send patient data securely from the palm of the patients hand to Sentrian’s remote patient monitoring platform (Sentrian RPI). Parallel 6 will power Sentrian mobile applications to help care teams better engage with chronic disease patients, turning patient self-report data into another data input for the Sentrian powerful analytics engine.
Clinical Reach is a HIPAA compliant, end-to-end patient lifecycle management and engagement platform. Its ReachLink Connector’s ability to securely collect large amounts of patient data in real-time via mobile and send through to the Sentrian RPI platform will securely serve both patients and care teams in multiple languages around the world.
“As we combine our solution with Sentrian’s award winning RPI platform, our technology changes the way patients and healthcare providers evaluate their health,” said CEO of Parallel 6, Allan Camaisa. “Our technologies are empowering people all over the world to securely communicate.”
“We’re always seeking to provide our care teams and patients with the most effective interaction tools and platforms,” said Co-Founder, Chief Executive Officer of Sentrian, Dean Sawyer. “Together, we’re helping improve patient outcomes, reduce avoidable costs and improve patient satisfaction for those dealing with complex chronic disease.”
Parallel 6 is an exhibitor at the DIA 2015 51st Annual Meeting gathering in Washington, D.C. Booth #1957. Parallel 6 CEO and Chairman, Allan Camaisa and President, CTO and Founder, David Turner, will be available for interviews and a demo of their technology platform.